Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-infected Children”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00000901
What this trial is testing

Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)Study completedNCT00109590
What this trial is testing

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 175
Not applicableStudy completedNCT00069004
What this trial is testing

Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth

Who this might be right for
HIV InfectionsHIV-Associated Lipodystrophy SyndromeHIV Lipodystrophy Syndrome+4 more
National Institute of Allergy and Infectious Diseases (NIAID) 450
Testing effectiveness (Phase 2)Study completedNCT00921557
What this trial is testing

Safety and Effectiveness of Alendronate for Bone Mineral Density in HIV-infected Children and Adolescents

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 52
Not applicableStudy completedNCT00164762
What this trial is testing

Nevirapine Resistance Study: Nevirapine Resistance Among HIV-Infected Mothers

Who this might be right for
HIV Infections
Centers for Disease Control and Prevention 126
Testing effectiveness (Phase 2)Study completedNCT00364793
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Efavirenz in HIV-Infected Children

Who this might be right for
HIV Infections
Bristol-Myers Squibb 56
Testing effectiveness (Phase 2)Study completedNCT00672412
What this trial is testing

Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 42
Post-approval studies (Phase 4)Study completedNCT02348177
What this trial is testing

Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB

Who this might be right for
Acquired Immunodeficiency SyndromeTuberculosis
Drugs for Neglected Diseases 96
Not applicableUnknownNCT01704144
What this trial is testing

Rifampin and Efavirenz Interactions in Older Children

Who this might be right for
HIVTuberculosis
The Miriam Hospital 160
Testing effectiveness (Phase 2)UnknownNCT00791700
What this trial is testing

An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children

Who this might be right for
Human Immunodeficiency Virus
ViiV Healthcare 103
Not applicableStudy completedNCT00541294
What this trial is testing

Diagnosis of Tuberculosis Infection in HIV Co-infected Children

Who this might be right for
Latent Tuberculosis InfectionTuberculosisHIV Infections
Case Western Reserve University 250
Large-scale testing (Phase 3)Study completedNCT03921424
What this trial is testing

Safety and Immunogenicity of V114 in Children Infected With Human Immunodeficiency Virus (HIV) (V114-030/PNEU-WAY PED)

Who this might be right for
Pneumococcal Infections
Merck Sharp & Dohme LLC 407
Not applicableStudy completedNCT05784584
What this trial is testing

Early Anti-Retroviral Treatment in HIV- Infected Children

Who this might be right for
HIV Infections
PENTA Foundation 220
Large-scale testing (Phase 3)Study completedNCT00330304
What this trial is testing

Isoniazid Prophylaxis With Concomitant Cotrimoxazole in HIV-infected Children

Who this might be right for
Tuberculosis
University of Cape Town 450
Testing effectiveness (Phase 2)Study completedNCT00260078
What this trial is testing

Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 75
Testing effectiveness (Phase 2)Study completedNCT00000963
What this trial is testing

Dideoxyinosine (ddI) in HIV-Infected Children Who Have Not Had Success With Zidovudine or Who Cannot Take Zidovudine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 300
Early research (Phase 1)Study completedNCT00000952
What this trial is testing

Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Not applicableStudy completedNCT00257127
What this trial is testing

Immune System Function Following Vaccination in HIV Infected Children Taking Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 101
Testing effectiveness (Phase 2)Study completedNCT00001066
What this trial is testing

A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination With Zidovudine in HIV-1 Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 740
Large-scale testing (Phase 3)Study completedNCT01825031
What this trial is testing

Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral Therapy

Who this might be right for
Human Immunodeficiency Virus
Anna Griffiths, MRC 1,805
Next Page